Mitochondrial toxicity has resulted in the withdrawal of several drugs from the market. One particular example is nefazodone, an anti-depressant withdrawn in the USA due to hepatoxicity caused by drug-induced mitochondrial dysfunction. Drug development and safety testing can involve the use of large numbers of laboratory animals, which, without a decisive pre-screening for mitochondrial toxicity, are often unable to pre-empt higher mortality rates in some patient groups. The use of isolated mitochondria as a screening tool for drug safety can decrease the number of laboratory animals used in pre-clinical studies, thus improving animal welfare and healthcare outcomes and costs. Novel techniques involving high-throughput methods can be used to investigate whether a molecule is a mitochondrial toxicant. Moreover, these screens are mechanistically-based, since the effects of the drug on oxidative phosphorylation, calcium homeostasis and mitochondrial genetics can be assessed. This review is intended to demonstrate that isolated mitochondrial fractions are suitable for predicting drug and general chemical safety in toxicological screenings, thus contributing to the refinement and reduction of animal use in laboratory research.
PereiraC.V., MoreiraA.C., PereiraS.P., MachadoN.G., CarvalhoF.S., SardãoV.A. & OliveiraP.J. (2009). Investigating drug-induced mitochondrial toxicity: a biosensor to increase drug safety? Current Drug Safety4, 34–54.
9.
CardosoS., SantosR.X., CarvalhoC., CorreiaS., PereiraG.C., PereiraS.S., OliveiraP.J., SantosM.S., ProençaT. & MoreiraP.I. (2008). Doxorubicin increases the susceptibility of brain mitochondria to Ca2+-induced permeability transition and oxidative phosphorylation. Free Radical Biology & Medicine45, 1395–1402.
10.
SardãoV.A., PereiraS.L. & OliveiraP.J. (2008). Drug-induced mitochondrial dysfunction in cardiac and skeletal muscle injury. Expert Opinion on Drug Safety7, 129–46.
11.
PereiraG.C., BrancoA.F., MatosJ.A., PereiraS.L., ParkeD., PerkinsE.L., SerafimT.L., SardãoV.A., SantosM.S., MorenoA.J., HolyJ. & OliveiraP.J. (2007). Mitochondrially targeted effects of berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxy-benzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 mouse melanoma cells: Comparison with direct effects on isolated mitochondrial fractions. The Journal of Pharmacology & Experimental Therapeutics323, 636–649.
12.
MorenoA.J., SerafimT.L., OliveiraP.J. & MadeiraV.M. (2007). Inhibition of mitochondrial bioenergetics by carbaryl is only evident for higher concentrations — Relevance for carbaryl toxicity mechanisms. Chemosphere66, 404–411.
13.
KakkarP. & SinghB.K. (2007). Mitochondria: a hub of redox activities and cellular distress control. Molecular Cell Biochemistry305, 235–253.
14.
HaroldF.M. (1986). The Vital Force, A Study in Bioenergetics, 577 pp. New York, NY, USA: W.H. Freeman and Company.
15.
NichollsD.G. & FergusonS.J. (1992). Bioenergetics 3, 297 pp. Amsterdam, The Netherlands: Academic Press.
16.
GreenD.R. & KroemerG. (2004). The pathophysiology of mitochondrial cell death. Science, New York305, 626–629.
LenazG. (2001). The mitochondrial production of reactive oxygen species: Mechanisms and implications in human pathology. IUBMB Life52, 159–164.
19.
WallaceD.C. (2008). Mitochondria as chi. Genetics179, 727–735.
20.
LeytinV., AllenD.J., MutluA., GyulkhandanyanA.V., MykhaylovS. & FreedmanJ. (2009). Mitochondrial control of platelet apoptosis: effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore. Laboratory Investigation89, 374–384.
21.
RoyS.S. & HajnóczkyG. (2008). Calcium, mitochondria and apoptosis studied by fluorescence measurements. Methods46, 213–233.
22.
BernardiP. & RasolaA. (2007). Calcium and cell death: the mitochondrial connection. Subcellular Biochemistry45, 481–506.
23.
MurphyM.P. (2009). How mitochondria produce reactive oxygen species. Biochemical Journal417, 1–13.
24.
BrownG.C. & BorutaiteV. (2007). Nitric oxide and mitochondrial respiration in the heart. Cardiovascular Research75, 283–290.
25.
ScatenaR., BottoniP., GiorgiaB., MartoranaG.E. & GiardinaB. (2007). The role of mitochondria in pharmacotoxicology: a re-evaluation of an old, newly emerging topic. American Journal Physiology — Cell Physiology293, 12–21.
26.
BrunmairB., LestA., StaniekK., GrasF., ScharfN., RodenM., NohlH., WaldhausW. & FurnsinnC. (2004). Fenofibrate impairs rat mitochondrial function by inhibition of respiratory complex I. Journal of Pharmacology & Experimental Therapeutics311, 109–114.
27.
HunterD.R. & HoworthR.A. (1979). The Ca2+-induced membrane transition in mitochondria — I. The protective mechanisms. Archives of Biochemistry & Biophysics195, 453–459.
28.
RasolaA. & BernardiP. (2007). The mitochondrial permeability transition pore and its involvement in cell death in disease pathogenesis. Apoptosis12, 815–833.
29.
BainesC.P. (2009). The molecular composition of the mitochondrial permeability transition pore. Journal of Molecular & Cellular Cardiology46, 850–857.
30.
BernardiP. (1999). Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiological Reviews79, 1127–1155.
LemastersJ.J., NieminenA.L., QianT., TrostL.C., ElmoreS.P., NishimuraY., CroweR.A., CascioW.E., BradhamC.A., BrennerD.A. & HermanB. (1998). The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochimica et Biophysica Acta1366, 177–196.
33.
LiL., HanW., GuY., QiuS., LuQ., JinJ., LuoJ. & HuX. (2007). Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore. Cancer Research67, 4894–4903.
34.
KamoN., MuratsuguM., HongohR. & KobatakeY. (1979). Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. Journal of Membrane Biology49, 105–121.
35.
MorenoA.J.M. & MadeiraV.M.C. (1991). Mitochondrial bioenergetics as affected by DDT. Biochimica et Biophysica Acta1060, 166–174.
36.
SilvaE.M., SoaresA.M.V.M., SobralO.M.F., LopesI.M.C.A., CorreiaJ.F.J.S., MarchanteE.M.D.C., ChastinetC.B.A. & MorenoA.J.M. (1998). Ecotoxicological responses of isolated mitochondrial systems to complex effuents, are they worthwhile?Chemosphere, 37, 2695–2701.
37.
SilvaE.M., SoaresA.M.V.M. & MorenoA.J.M. (1998). The use of the mitochondrial transmembrane potential as an effective biosensor in ecotoxi-cological research. Chemosphere, 36, 2375–2390.
38.
BlondinG.A., KnobelochL.M., ReadH.W. & HarkinJ.M. (1988). An in vitro submitochondrial bioassay for predicting acute toxicity in fish. In Aquatic Toxicology & Environmental Fate, Eleventh Volume, ASTM STP 1007, (ed. SuterG.W. & LewisM.A.), pp. 551–563. Conshohocken, PA, USA: American Society for Testing and Materials International.
39.
RoloA.P., PalmeiraC.M. & CortopassiG.A. (2009). Biosensor plates detect mitochondrial physiological regulators and mutations in vivo. Analytical Biochemistry385, 176–178.
